| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
21 |
| Employees |
485 |
| Revenues (TTM) (Millions $) |
125 |
| Net Income (TTM) (Millions $) |
-60 |
| Cash Flow (TTM) (Millions $) |
-32 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Endologix Inc. is a medical technology firm specializing in the manufacture and supply of minimally invasive treatment solutions for aortic disorders. Established in 1992, Endologix has its headquarters in Irvine, California, and has a global presence in over 60 countries. Endologix utilizes its extensive expertise in vascular medical technology to develop innovative products designed to treat a variety of aortic-related diseases such as aneurysms and dissections.
Endologix is dedicated to patient-centric care and has a mission to provide affordable, minimally invasive solutions that facilitate an improved quality of life for individuals diagnosed with potentially life-threatening aortic diseases. This mission is accomplished through the provision of best-in-class solutions that incorporate advanced technology and patient-focused design. In this regard, the company strives to maintain a culture of innovation and research through partnerships with leading physicians and medical institutions.
The company's product portfolio includes industry-leading differentiated solutions such as the Ovation Abdominal Stent Graft System, the Nellix Endovascular Aneurysm Sealing System, and AFX Endovascular AAA System, which enables physicians to provide efficient and effective management of aortic disease. These solutions incorporate groundbreaking advancements such as a unique engineered polymer system, ultra-low profile stent graft, and active sealing technology.
Endologix has an extensive distribution network that includes a team of highly trained professionals, authorized distributors, or physicians with medical device distribution capabilities, ensuring the products reach the targeted patient population. Additionally, the company continuously invests in enhancing its distribution channel through training, education, and support.
In conclusion, Endologix Inc is a global healthcare company that plays a pivotal role in the field of minimally invasive treatments of aortic diseases. Its emphasis on innovative solutions, culture of research, and commitment to providing maximum benefits to the patient by working collaboratively with industry-leading physicians and medical institutions, augurs well for its success in the medical technology field. Ultimately, Endologix seeks to revolutionize the management of aortic diseases through its innovative solutions, coupled with exceptional patient care.
|
%